Yaşar Çalışkan

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

Krzysztof Kiryluk, Elena Sánchez, Francesca Zanoni et al. · Nature Genetics · 2023 · 156 citations · Full text

Genome-wide Association Study, Glomerulonephritis, Genome-wide Association +15

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

Rosanna Coppo, Graziella D’Arrigo, Giovanni Tripepi et al. · Nephrology Dialysis Transplantation · 2018 · 105 citations · Full text

Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy

Rupali S. Avasare, Pietro A. Canetta, Andrew S. Bomback et al. · Clinical Journal of the American Society of Nephrology · 2018 · 98 citations

Genomic Mismatch at <i>LIMS1</i> Locus and Kidney Allograft Rejection

Nicholas J. Steers, Yifu Li, Zahida Drače et al. · New England Journal of Medicine · 2019 · 93 citations · Full text

Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

Rosanna Coppo, Danilo Lofaro, Roberta Camilla et al. · Pediatric Nephrology · 2016 · 91 citations · Full text

Glomerular Disease, Glomerulonephritis, Renal Disease +11